In this series of videos, International Chair of Life Sciences Cheryl Reicin provides valuable insights on a number of trends she is seeing in Big Pharma dealmaking and M&A. She discusses 2025 deal trends, M&A drivers, patent cliff impacts, and the hottest emerging sectors.

Drivers of Big Pharma M&A 

Big Pharma Patent Cliff Impacts to M&A 

What are the Hottest Sectors in the Life Science Industry? 

Central Nervous System (CNS) Investment Opportunities 

How Do You See Big Pharmas in AI?